A CRISPR/Cas approach to treat β-hemoglobinopathies (FR)

12 February 2025 PublicationsScientific articles EDITSCD

Brusson, Megane, et Annarita Miccio. « Une approche CRISPR/Cas pour traiter les β-hémoglobinopathies ». médecine/sciences, vol. 41, n^o 1, janvier 2025, p. 33‑39. www.medecinesciences.org, https://doi.org/10.1051/medsci/2024191

:: Previous

An New European survey on “Artificial Intelligence in Haematology: Knowledge and Perspectives” has been lauched by ERN-EuroBloodNet!

EHA Research Conference 2025

Related informations

PublicationsScientific articles

Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges

Kalter, Nechama, et al. "Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges". https://doi.org/10.1016/j.omtn.2025.102636

EDITSCD

PublicationsScientific articles

Genome Editing with the HDR-Enhancing DNA-PKcs Inhibitor AZD7648 Causes Large-Scale Genomic Alterations

Cullot, Grégoire, et al. « Genome Editing with the HDR-Enhancing DNA-PKcs Inhibitor AZD7648 Causes Large-Scale Genomic Alterations ». Nature Biotechnology, vol. 43, [...]

EDITSCD

PublicationsScientific articles

Editing the Core Region in HPFH Deletions Alters Fetal and Adult Globin Expression for Treatment of β-Hemoglobinopathies

Venkatesan, Vigneshwaran, et al. « Editing the Core Region in HPFH Deletions Alters Fetal and Adult Globin Expression for Treatment of [...]

EDITSCD

Project
- Workplan
- Impact
Consortium
- Partners
- Collaborators
Publications
- News
- Scientific articles
Events
- Project meetings
- Scientific events
Contact

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101057659

Home
Project
Publications
Events
Consortium
Contact

We use cookies to ensure you get the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy Policy